ChiCTR2000031492 版本V1.1 版本创建时间2020/04/02 21:03:59 中国临床试验注册中心

审核状态:

Project audit state:

通过审核

Successful

注册号:

Registration number:

ChiCTR2000031492 

最近更新日期:

Date of Last Refreshed on:

2020-04-02 20:50:31 

注册时间:

Date of Registration:

1990-01-01 00:00:00 

注册号状态:

预注册

Registration Status:

Prospective registration

注册题目:

前交叉韧带损伤后患者膝关节内软骨细胞衰老积累程度与骨关节炎的进展关系的临床研究

Public title:

Study of Relationship Between Senescent Cells Accumulation and Progression of Osteoarthritis After Anterior Cruciate Ligament Tear

注册题目简写:

English Acronym:

研究课题的正式科学名称:

前交叉韧带损伤后膝关节内软骨细胞衰老积累程度与骨关节炎的进展关系

Scientific title:

Relationship Between Senescent Cells Accumulation and Progression of Osteoarthritis After Anterior Cruciate Ligament Tear

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

王立人 

研究负责人:

赵金忠 

Applicant:

Liren Wang 

Study leader:

Jinzhong Zhao 

申请注册联系人电话:

Applicant telephone:

18817627028

研究负责人电话:

Study leader's
telephone:

13917396491

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

wangliren13@163.com

研究负责人电子邮件:

Study leader's E-mail:

jzzhao@sjtu.edu.cn

申请单位网址(自愿提供):

Applicant website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website(voluntary supply):

申请注册联系人通讯地址:

上海市徐汇区宜山路600号上海市第六人民医院

研究负责人通讯地址:

上海市徐汇区宜山路600号上海市第六人民医院

Applicant address:

Shanghai Jiao Tong University affiliated Shanghai Sixth People’s Hospital, 600 Yishan Road, Shanghai, China

Study leader's address:

Shanghai Jiao Tong University affiliated Shanghai Sixth People’s Hospital, 600 Yishan Road, Shanghai, China

申请注册联系人邮政编码:

Applicant postcode:

200233

研究负责人邮政编码:

Study leader's postcode:

200233

申请人所在单位:

上海市第六人民医院

Applicant's institution:

Shanghai Jiao Tong University affiliated Shanghai Sixth People’s Hospital

研究负责人所在单位:

上海市第六人民医院

Affiliation of the Leader:

Shanghai Jiao Tong University affiliated Shanghai Sixth People’s Hospital

是否获伦理委员会批准:

Approved by ethic committee:

No

伦理委员会批件文号:

Approved No. of ethic committee:

伦理委员会批件附件:

Approved file of Ethical Committee:

批准本研究的伦理委员会名称:

Name of the ethic committee:

伦理委员会批准日期:

Date of approved by ethic committee:

2013-08-26 00:00:00

伦理委员会联系人:

Contact Name of the ethic committee:

伦理委员会联系地址:

Contact Address of the ethic committee:

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

上海市第六人民医院

Primary sponsor:

Shanghai Jiao Tong University affiliated Shanghai Sixth People’s Hospital

研究实施负责(组长)单位地址:

上海市徐汇区宜山路600号上海市第六人民医院

Primary sponsor's address:

Shanghai Jiao Tong University affiliated Shanghai Sixth People’s Hospital, 600 Yishan Road, Shanghai, China

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

上海市

市(区县):

徐汇区

Country:

China

Province:

Shanghai

City:

Xuhui District

单位(医院):

上海市第六人民医院

具体地址:

宜山路600号

Institution
hospital:

Shanghai Jiaotong University affiliated Shanghai Sixth People's Hospital

Address:

600 Yishan Road

经费或物资来源:

国家自然科学基金

Source(s) of funding:

National Natural Science Foundation of China

研究疾病:

关节炎  

Target disease:

arthritis

研究疾病代码:

Target disease code:

研究类型:

观察性研究

Study type:

Observational study

研究所处阶段:

其它 

Study phase:

N/A

研究设计:

病例研究 

Study design:

Case study 

研究目的:

探究前交叉韧带损伤后患者膝关节内软骨细胞衰老积累程度与骨关节炎的进展关系。  

Objectives of Study:

Discovery the relationship between senescennt cells accumulation in cartilage after anterior cruciate ligament

药物成份或治疗方案详述:

 

Description for medicine or protocol of treatment in detail:

 

纳入标准:

① 患者年龄5~70岁,性别不限;
② 磁共振提示前交叉韧带损伤患者,Lachman试验和前抽屉试验松弛2度以上;
③关节屈膝可达120°;
④受试者同意参加本试验,并签署“受试者知情同意书”;
⑤患者愿意密切配合医生制订的严格的术后康复程序签署知情同意书。

Inclusion criteria

① Age 5-70, both gender;
② Anterior cruciate ligament tear verified by MRI. Laxity of lachman and anterior drawer was over class II;
③ Flexion of knee is over 120 degree;
④ Patients are willing to attend the test and sign informed consent;
⑤ Patients are willing to cooperate with doctor.

排除标准:

① 精神、心理异常者;
② 患者过于肥胖,体重指数>35;
③ 多组韧带损伤;
④不能或不愿意接受康复训练者;
⑤ 有严重的关节强直或关节纤维化者;
⑥ 过去六个月内接受过膝关节开放手术者;
⑦ 血钙/游离钙异常,具有严重的原发性心血管病变、肺脏疾病、内分泌及代谢性疾病或影响其生存的严重疾病,如肿瘤或艾滋病,研究者认为不宜入选者;
⑧ 妊娠期、哺乳期妇女,或计划于试验期间受孕者,试验前尿HCG检查结果阳性者,月经期妇女;
⑨ 其他急慢性疾病,研究者认为不宜手术者。

Exclusion criteria:

① Mental disorder;
② Obesity, BMI > 35;
③ Multiple ligament tear;
④ Unwilling to attend covery training;
⑤ Severe ankylosis or ankle fibrillation;
⑥ Open knee surgery in the past six months;
⑦ Blood Calcium / free calcium abnormalities, severe primary cardiovascular, pulmonary, endocrine, tumor or HIV disease,
⑧ Female in gestation period, breastfeeding, pregnancy in schedule, HCG positive in urine or menses;
⑨ Other disease which is not appropriate for surgery determined by surgeon.

研究实施时间:

Study execute time:

From 2020-01-01 00:00:00 To 2023-12-31 00:00:00  

征募观察对象时间:

Recruiting time:

From 2020-06-01 00:00:00 To 2022-12-31 00:00:00

干预措施:

Interventions:

组别:

按年龄分组:<18岁组,18-55岁组,55岁以上组

样本量:

24

Group:

Group by age: <18 years vs. 18-55 years vs. >55 years

Sample size:

干预措施:

干预措施代码:

Intervention:

N/A

Intervention code:

组别:

按术后拖延时间分组:<3月组,3-6月组,>6月组

样本量:

24

Group:

Group by postoperative delay time: <3 months group vs.3-6 months group vs. >6 months group

Sample size:

干预措施:

干预措施代码:

Intervention:

N/A

Intervention code:

研究实施地点:

Countries of recruitment and research settings:

国家:

中国

省(直辖市):

上海 

市(区县):

徐汇区 

Country:

China

Province:

Shanghai

City:

Xuhui District

单位(医院):

上海市第六人民医院 

单位级别:

三甲 

Institution
hospital:

Shanghai Jiaotong University affiliated Shanghai Sixth People's Hospital

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

软骨及衰老细胞

指标类型:

主要指标

Outcome:

Cartilage and senescent cells

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

膝关节软骨状态

指标类型:

主要指标

Outcome:

Cartilage state of knee joint

Type:

Primary indicator

测量时间点:

测量方法:

膝关节磁共振检查

Measure time point of outcome:

Measure method:

MRI of knee joint

指标中文名:

膝关节屈曲、前伸角度

指标类型:

次要指标

Outcome:

Flexion and extension angle of knee joint

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

骨关节炎指数

指标类型:

次要指标

Outcome:

WOMAC

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

疼痛评分

指标类型:

次要指标

Outcome:

VAS

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

软骨

组织:

Sample Name:

cartilage

Tissue:

bone

人体标本去向

使用后保存  

说明

保存6个月

Fate of sample:

Preservation after use  

Note:

Storation for 6 months

标本中文名:

半月板

组织:

Sample Name:

meniscus

Tissue:

bone

人体标本去向

使用后保存  

说明

保存6个月

Fate of sample:

Preservation after use  

Note:

Storation for 6 months

标本中文名:

韧带残端

组织:

韧带

Sample Name:

remnant of ligament

Tissue:

ligament

人体标本去向

使用后保存  

说明

保存6个月

Fate of sample:

Preservation after use  

Note:

Storation for 6 months

标本中文名:

滑膜

组织:

Sample Name:

synovial membrane

Tissue:

人体标本去向

使用后保存  

说明

Fate of sample:

Preservation after use  

Note:

征募研究对象情况:

Recruiting status:

尚未开始

Not yet recruiting

年龄范围:

Participant age:

最小 Min age years
最大 Max age years

性别:

男女均可

Gender:

Both

随机方法(请说明由何人用什么方法产生随机序列):

无随机

Randomization Procedure (please state who generates the random number sequence and by what method):

No randomization

是否公开试验完成后的统计结果:

Calculated Results after the Study Completed public access:

公开/Public

盲法:

Blinding:

试验完成后的统计结果(上传文件):

Calculated Results after
the Study Completed(upload file):

是否共享原始数据:

IPD sharing

是Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

公布于ResMan, 2024.06

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

Published in ResMan, 2024.06

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

通过ResMan进行数据的电子采集和管理

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

ResMan was used for data collection and management

数据与安全监察委员会:

Data and Safety Monitoring Committee:

有/Yes

注册人:

Name of Registration:

 2020-04-02 20:49:40